glp-1 drugs mounjaro analogs, new trend in obesity treatment, become even more effective < Pharma < Article Use of the dual GIP/GLP-1
Description
8 Thus, it fosters reduction in appetite, food quantity and calorie intake
Schoretsanitis, G., Weiler, S., Barbui, C., Raschi, E

Thaibah, O

Ozer discusses new #GLP1 medications to help lower blood sugar

GLP-1 receptor agonists obesity drugs market captured the largest revenue share of 81% in 2024 within North America, driven by high obesity prevalence, early drug approvals, and robust healthcare infrastructure

Diversifying suppliers and making long-term partnerships to secure capacity should be big parts of procurement plans
